Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 29
Filter
Add more filters










Publication year range
1.
Ann Fr Anesth Reanim ; 26(6): 604-7, 2007 Jun.
Article in French | MEDLINE | ID: mdl-17433609

ABSTRACT

Pneumocystis jiroveci pneumonia is a classic opportunist infection affecting AIDS patients. However it is less frequent since systematic prophylaxis and antiretroviral therapies. Treatment resistance is rare in France. We report the case of a severe Pneumocystis jiroveci pneumonia with treatment resistance to standard treatment and fatal outcome. The different causes of treatment resistance, notably the role of CMV co-infection, were reviewed and discussed.


Subject(s)
Anti-Infective Agents/pharmacology , Cytomegalovirus Infections/complications , Pneumocystis carinii , Pneumonia, Pneumocystis/drug therapy , Pneumonia, Pneumocystis/virology , Trimethoprim, Sulfamethoxazole Drug Combination/pharmacology , Drug Resistance, Bacterial , Fatal Outcome , Humans , Male , Middle Aged
2.
Am J Physiol Heart Circ Physiol ; 279(2): H650-6, 2000 Aug.
Article in English | MEDLINE | ID: mdl-10924064

ABSTRACT

We investigated the role of the cAMP link to the signal transduction mechanism coupled with adenosine A(2A) and A(2B) receptors in cultured human coronary artery endothelial cells (HCAEC) and porcine coronary artery endothelial cells (PCAEC). 2-[4-[2-¿2-[(4-aminophenyl)methylcarbonylamino]ethylaminocarbon yl¿eth yl]phenyl]ethylamino-5'- ethylcarboxamidoadenosine ((125)I-PAPA-APEC) (PAPA-APEC) was used to demonstrate the specific binding in PCAEC membranes. The specific binding was saturable and reversible with a maximal number of binding sites (B(max)) of 240 fmol/mg protein, and scatchard analysis revealed a single class of binding site with an equilibrium dissociation constant (K(d)) of 1. 17 +/- 0.035 nM. In competition experiments, adenosine receptor agonists showed the following order of potency (based on IC(50)): 5'-(N-ethylcarboxamido)adenosine (NECA) >/= CGS-21680 > 2-chloroadenosine. This order appears to be consistent with the A(2) adenosine receptor classification. We also studied the effects of adenosine agonists on the accumulation of cAMP as an indirect approach to show the presence of functional A(2) receptors. Similarly, the same adenosine agonists (10(-7)-10(-4) M) elicited the production of cAMP in intact endothelial cells in a dose-dependent manner, exhibiting consistently with the A(2) adenosine receptor classification. A selective A(2A) adenosine receptor antagonist (ZM-241385, 10(-8) M) significantly inhibited the effect of CGS-21680 on cAMP but only partly inhibited the effect of NECA, suggesting the presence of both A(2A) and A(2B) receptors. Western blot analysis further showed the immunoreactivity of A(2A) and A(2B) receptor at 45 and 36 kDa, respectively, in both HCAEC and PCAEC. Direct evidence for the presence of A(2A) and A(2B) receptors in cultured HCAEC and PCAEC by reverse transcription-polymerase chain reaction (RT-PCR), revealed expected PCR product sizes (205 and 173 bp) for A(2A) and A(2B) receptors in HCAEC and PCAEC, respectively. The data show that adenylate cyclase-coupled adenosine A(2A) and A(2B) receptors are present in coronary endothelial cells.


Subject(s)
Coronary Vessels , Cyclic AMP/metabolism , Endothelium, Vascular/physiology , Gene Expression Regulation , Receptors, Purinergic P1/metabolism , 2-Chloroadenosine/pharmacology , Adenosine/analogs & derivatives , Adenosine/pharmacokinetics , Adenosine/pharmacology , Adenosine-5'-(N-ethylcarboxamide)/pharmacology , Affinity Labels , Animals , Binding, Competitive , Cells, Cultured , Endothelium, Vascular/cytology , Endothelium, Vascular/drug effects , Humans , Iodine Radioisotopes , Iodobenzenes/pharmacokinetics , Kinetics , Phenethylamines/pharmacology , Purinergic P1 Receptor Antagonists , Radioligand Assay , Receptor, Adenosine A2A , Receptor, Adenosine A2B , Receptors, Purinergic P1/genetics , Reverse Transcriptase Polymerase Chain Reaction , Swine , Transcription, Genetic , Triazines/pharmacology , Triazoles/pharmacology
3.
J Exp Zool ; 285(1): 41-9, 1999 Apr 15.
Article in English | MEDLINE | ID: mdl-10327649

ABSTRACT

The physical mapping of Hox gene clusters from a limited number of vertebrates has shown an overall conservation in gene organization in which major evolutionary changes appear to be primarily restricted to the deletion of one or more genes, with the exception of the amplification of additional clusters as postulated from zebrafish. We have sequenced a 31 kb region of the HoxA cluster from the teleost Morone saxatilis (striped bass), both to provide a detailed physical map of this region and to better understand the nature of Hox cluster evolution among vertebrate taxa. We identified five linked Hox genes: Hoxa4, Hoxa5, Hoxa7, Hoxa9, and Hoxa10, which are organized similarly to those of other vertebrates. Furthermore, we have documented the absence of the Hoxa6 and Hoxa8 genes within the 31 kb contig. Comparison of our results to those published for other vertebrates suggests that the absence of Hoxa6 is a common characteristic of teleosts, whereas the absence of Hoxa8 is common to vertebrates in general, with the possible exception of zebrafish. Further comparisons between the HoxA genes from Morone with those from the pufferfish, Fugu rubripes, revealed the likely presence of a previously unreported Hoxa7 gene, or gene fragment, in the Fugu genome, which suggests that the Hoxa7 gene, unlike Hoxa6 or Hoxa8, is present in teleosts. In addition to these differences in vertebrate Hox cluster structure, we also observed a marked reduction in the length of the Hoxa4--a10 region between vertebrate lineages representative of teleosts and mammals. Comparative analysis of HoxA cluster organization among teleosts and mammals suggests that cluster length reduction and lineage-specific gene loss events are hallmarks of Hox cluster evolution.


Subject(s)
Bass/genetics , DNA-Binding Proteins/genetics , Evolution, Molecular , Genes, Homeobox , Homeodomain Proteins/genetics , Amino Acid Sequence , Animals , Databases, Factual , Gene Library , Genetic Linkage , Homeobox A10 Proteins , Molecular Sequence Data
4.
Regul Pept ; 52(1): 31-8, 1994 Jun 16.
Article in English | MEDLINE | ID: mdl-7972929

ABSTRACT

Gastrin and cholecystokinin (CCK) have proven trophic effects on the gut. We have previously demonstrated that these peptides stimulate an early event in cellular proliferation, namely ornithine decarboxylase activity (ODC), in a rat exocrine pancreatic cell line AR4-2J. Furthermore, this effect is mediated through a G/CCKB receptor. Thus, in the present study we sought to examine the signal transduction mechanisms linked to the G/CCKB receptor occupancy. Both gastrin and CCK induced a rapid (maximum at 40 s) increase in inositol triphosphates (InsP3) and diacylglycerol (DAG) formation in a dose-dependent manner (EC50 = 5.6 nM) that quickly returned to baseline. Although InsP3 levels remained at baseline, DAG levels demonstrated a second gradual increase that was maximal at 15 min. CCK/gastrin efficiency to stimulate DAG and InsP3 formation (EC50 = 5.6 nM) could be correlated to the G/CCKB receptor occupancy, suggesting a coupling of this receptor to phospholipase C. To examine the involvement of protein kinase C (PKC) activation in the increase in ODC activity, we stimulated the AR4-2J cells with the phorbol ester TPA and observed an increase in ODC activity with a maximal effect at 100 nM. TPA stimulation of ODC activity was completely abolished by the PKC inhibitor staurosporine (50 nM). However, 50 nM staurosporine inhibited only 65% of the gastrin and CCK induced increase in ODC activity suggesting that a portion of the G/CCKB receptor-mediated increase in ODC activity is PKC independent.


Subject(s)
Protein Kinase C/metabolism , Receptors, Cholecystokinin/metabolism , Type C Phospholipases/metabolism , Alkaloids/pharmacology , Animals , Binding Sites , Cholecystokinin/pharmacology , Diglycerides/metabolism , Dose-Response Relationship, Drug , Enzyme Activation/drug effects , Enzyme Activation/physiology , Gastrins/pharmacology , Inositol 1,4,5-Trisphosphate/metabolism , Inositol Phosphates/metabolism , Ornithine Decarboxylase/metabolism , Pancreas/metabolism , Pancreatic Neoplasms/metabolism , Phosphatidylinositol 4,5-Diphosphate , Phosphatidylinositol Phosphates/metabolism , Protein Kinase C/antagonists & inhibitors , Rats , Signal Transduction/physiology , Staurosporine , Tetradecanoylphorbol Acetate/pharmacology , Tumor Cells, Cultured
5.
Am J Physiol ; 265(5 Pt 1): G851-6, 1993 Nov.
Article in English | MEDLINE | ID: mdl-8238513

ABSTRACT

High levels of polyamines have been identified in the lumen of the intestines. Luminal polyamines are involved in normal mucosal growth and may be the primary source of extracellular polyamines for tumors grown in animals undergoing polyamine antimetabolite therapy. The vectorial movement of polyamines across an in vitro model of the gut was studied in epithelial cells grown in culture. IEC-6 cells were plated on either plastic or raised inserts. Cells grown on plastic were employed to define the kinetic constants for putrescine and spermidine uptake. Eadie-Hofstee plot analysis of putrescine uptake was characteristic of a single class of transporter with a Michaelis constant (Km) of 4.85 +/- 0.57 microM and a maximal velocity (Vmax) of 627 +/- 85 pmol x 15 min-1 x 10(6) cells-1. The plot for spermidine uptake was curvilinear and representative of the interaction of spermidine with two sites: Km 1 and 2 are 0.26 +/- 0.13 and 2.1 +/- 0.77 microM; Vmax 1 and 2 are 177 +/- 50 and 429.5 +/- 70 pmol x 15 min-1 x 10(6) cells-1, respectively. Calmodulin antagonism blocked the uptake of putrescine and the low-affinity but not high-affinity spermidine uptake system. Seven-day postconfluent cells grown on plastic inserts were used to study the vectorial movement of polyamines in a polarized epithelium. The apical membrane domain expressed two sites with similar kinetic constants to those observed when cells were grown on plastic. In contrast, however, the basolateral membrane did not transport polyamines. Spermidine uptake through this membrane was only a fraction of that in the apical membrane and was completely nonspecific.(ABSTRACT TRUNCATED AT 250 WORDS)


Subject(s)
1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine/analogs & derivatives , Duodenum/metabolism , Putrescine/metabolism , Spermidine/metabolism , Azepines/pharmacology , Biological Transport/drug effects , Calmodulin/antagonists & inhibitors , Cell Line , Epithelium/metabolism , Humans , Imidazoles/pharmacology , Isoquinolines/pharmacology , Kinetics , Naphthalenes/pharmacology , Piperazines/pharmacology , Protein Kinase Inhibitors , Sulfonamides/pharmacology
6.
Toxicol Appl Pharmacol ; 122(1): 95-100, 1993 Sep.
Article in English | MEDLINE | ID: mdl-8378935

ABSTRACT

Although the major target organ of paraquat toxicity is the lung, the primary route of absorption of the herbicide is across the gastrointestinal epithelium. Thus, uptake of paraquat was investigated in the rat duodenal crypt cell line, IEC-6. The herbicide was toxic; as measured by cell number, the LD50 was 75 microM. Using 2 microM [14C]paraquat as tracer, uptake of the herbicide was found to be slow but linear over 24 hr at 37 degrees C. No accumulation was observed at 4 degrees C. Inhibition studies showed paraquat inhibited both putrescine and spermidine uptake after only a 15-min incubation. The Km for putrescine was increased when incubated in the presence of paraquat whereas Vmax was not changed, suggesting a competitive mode of inhibition. In the reverse situation, putrescine also inhibited paraquat uptake (IC50 10 microM). Paraquat uptake was reduced in a dose-dependent manner by the putative calmodulin antagonist W-7, but was not affected by KN-62, a Ca2+/calmodulin kinase II specific inhibitor. These results provide evidence that paraquat uptake occurs through the polyamine transport system in IEC-6 cells. Furthermore, this process is modulated by intracellular events involving a major signaling protein, Ca2+/calmodulin.


Subject(s)
1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine/analogs & derivatives , Intestinal Mucosa/metabolism , Paraquat/pharmacokinetics , Animals , Binding, Competitive , Calmodulin/antagonists & inhibitors , Calmodulin/metabolism , Cell Count/drug effects , Cell Line , Intestinal Mucosa/drug effects , Isoquinolines/pharmacology , Paraquat/toxicity , Piperazines/pharmacology , Putrescine/pharmacokinetics , Putrescine/pharmacology , Rats , Spermidine/pharmacokinetics , Spermidine/pharmacology , Sulfonamides/pharmacology
7.
Gastroenterology ; 103(3): 1002-8, 1992 Sep.
Article in English | MEDLINE | ID: mdl-1323494

ABSTRACT

In the present work the effects of the novel neuropeptide Pituitary Adenylate Cyclase Activating Peptide (PACAP) on both AR4-2J cell growth and the modulation of ornithine decarboxylase activity were investigated. Both PACAP38 and the amidated form PACAP27 caused a concentration-dependent stimulation of AR4-2J cell growth; the maximal increase was seen at 1 nmol/L (30% above control, P less than 0.01) with a half-maximal effect at 0.01 nmol/L. Ornithine decarboxylase activity was also increased by PACAP in a dose-dependent manner, reaching half-maximal stimulation at 0.5 nmol/L. The addition of 1 nmol/L of somatostatin analog SMS 201-995 totally suppressed PACAP-stimulated AR4-2J cell growth. Vasoactive intestinal polypeptide (3 mumol/L) and 8-bromo-cyclic adenosine monophosphate (1 mmol/L) had no effect on cell proliferation. Treatment of cells by pertussis toxin (25 ng.mL-1.day-1) suppressed PACAP-stimulated AR4-2J cell growth but enhanced PACAP-induced stimulation of adenylate cyclase activity. It was concluded that PACAP stimulates AR4-2J cell proliferation by a mechanism that seems independent of cyclic adenosine monophosphate production. The mitogenic effect of PACAP depends on a pertussis toxin-sensitive G protein and is associated with an increase of ornithine decarboxylase activity.


Subject(s)
Neuropeptides/pharmacology , Pancreatic Neoplasms/pathology , Adenylate Cyclase Toxin , Adenylyl Cyclases/metabolism , Animals , Cell Count , Cell Division/drug effects , Cyclic AMP/pharmacology , Dose-Response Relationship, Drug , Epidermal Growth Factor/pharmacology , Insulin/pharmacology , Octreotide/pharmacology , Ornithine Decarboxylase/metabolism , Pancreatic Neoplasms/metabolism , Pertussis Toxin , Pituitary Adenylate Cyclase-Activating Polypeptide , Rats , Tumor Cells, Cultured , Vasoactive Intestinal Peptide/pharmacology , Virulence Factors, Bordetella/pharmacology
8.
Pancreas ; 7(6): 657-63, 1992.
Article in English | MEDLINE | ID: mdl-1280364

ABSTRACT

Basic fibroblast growth factor (bFGF) is a potent mitogen for various cell types. Induction of ornithine decarboxylase (ODC) activity is one of the early events triggered in proliferating cells. Our aim was to study the effect of bFGF on ODC activity and ODC mRNA expression in a pancreatic tumoral cell line, AR4-2J. Following kinetic and dose-response studies, we found that maximal stimulation (150% over control) of ODC activity occurred after 3 h of bFGF treatment (10(-9) M), the EC50 being 20 pM. To elucidate the mechanism by which bFGF stimulates ODC activity, we measured the ODC mRNA levels by Northern blot hybridization using a 32P-labeled rat cDNA probe. In AR4-2J cells treated with bFGF at 10(-9) M over 120 min, ODC mRNA expression was transiently increased by 71.6% at 60 min. Furthermore, bFGF was also able to stimulate ODC mRNA synthesis in the presence of cycloheximide. In conclusion, in AR4-2J cells of pancreatic origin, bFGF stimulates ODC gene transcription. This effect contributes to the stimulation of ODC enzymatic activity and to the proliferative effect of bFGF on this cell line.


Subject(s)
Fibroblast Growth Factor 2/pharmacology , Ornithine Decarboxylase/drug effects , Pancreatic Neoplasms/enzymology , RNA, Messenger/biosynthesis , Animals , Cell Division/drug effects , Cycloheximide/pharmacology , Kinetics , Ornithine Decarboxylase/genetics , Ornithine Decarboxylase/metabolism , Pancreatic Neoplasms/genetics , Protein Biosynthesis , RNA/isolation & purification , Rats , Transcription, Genetic/drug effects , Tumor Cells, Cultured
9.
Int J Cancer ; 49(4): 577-81, 1991 Oct 21.
Article in English | MEDLINE | ID: mdl-1917160

ABSTRACT

Polyamines are essential for cell growth and differentiation. Their specific uptake contributes to the regulation of intracellular polyamine levels. In this study, we describe the modulation of this transport mechanism in a rat tumoral pancreatic acinar cell line (AR4-2J) and analyze the transport system characteristics of the normal rat pancreatic acini. Normal acini had a common carrier for spermidine and spermine, like AR4-2J cells, but not a specific putrescine carrier. Intracellular polyamine deprivation enhanced putrescine and spermidine uptake of AR4-2J cells with no modification of polyamine carrier affinity. Uptake was modulated during growth and decreased for both polymaines at confluence. AR4-2J cell differentiation with dexamethasone prevented cell proliferation and diminished uptake of both putrescine and spermidine without affecting their respective carrier affinities. Our data show, first, that the polyamine transport system could be modulated by polyamine metabolism with no change in its affinity characteristics. Second, in rat pancreatic acinar cells, neoplastic transformation was partly characterized by induction of a high-affinity putrescine carrier. This phenotype was not reversed by dexamethasone-induced cell differentiation.


Subject(s)
Cell Division , Dexamethasone/pharmacology , Pancreas/metabolism , Putrescine/metabolism , Spermidine/metabolism , Animals , Biological Transport/drug effects , Cell Line , Cells, Cultured , Eflornithine/pharmacology , Kinetics , Male , Pancreas/drug effects , Pancreatic Neoplasms , Rats , Rats, Inbred Strains , Spermine/metabolism
10.
Cancer Res ; 50(18): 5829-33, 1990 Sep 15.
Article in English | MEDLINE | ID: mdl-2393852

ABSTRACT

Many reports emphasized the role of gastrin as growth factor on normal gastrointestinal mucosa and pancreas. In the present study, we analyzed the proliferative effects of cholecystokinin (CCK) and gastrin peptides on a rat tumoral pancreatic cell line, AR42J, which possesses both CCKA and CCKB receptor subtypes. The results showed a good correlation between the binding of gastrin to CCKB receptor [Kd 1.125 +/- 0.3 (SD) nM] and its ability to either induce ornithine decarboxylase activity [50% effective concentration, 0.6 +/- 0.3 nM] and [3H]-thymidine incorporation [50% effective concentration, 2 +/- 0.4 nM]. Furthermore, the ability of different cholecystokinin and gastrin antagonists such as proglumide and asperlicin derivatives (respectively, CR1409, CR1505, and L364,718) were tested. We found that all antagonists displaced 125I-labeled gastrin binding, with the following order of potencies: L364,718 greater than CR1409 greater than CR1505 greater than proglumide. Furthermore, the 50% inhibitory concentration of CR1409 and CR1505 to inhibit gastrin stimulated ornithine decarboxylase activity (an early event involved in cell proliferation) and [3H]thymidine incorporation were in agreement with their constants of inhibition (Ki) on gastrin binding. The L364,718 compound, at a concentration which fully occupied the CCKA without affecting the CCKB, had no effect on gastrin stimulated ornithine decarboxylase activity and [3H]thymidine incorporation. In addition, this compound appeared to be a full agonist on CCKB receptor. These results confirm the implication of the CCKB receptor in the proliferative response of AR42J cells to gastrin.


Subject(s)
DNA, Neoplasm/biosynthesis , Gastrins/pharmacology , Glutamine/analogs & derivatives , Pancreatic Neoplasms/metabolism , Proglumide/analogs & derivatives , Animals , Ornithine Decarboxylase/analysis , Pancreatic Neoplasms/pathology , Proglumide/pharmacology , Rats , Receptors, Cholecystokinin/analysis , Receptors, Cholecystokinin/physiology , Thymidine/metabolism , Tumor Cells, Cultured
11.
Biochem J ; 269(3): 629-32, 1990 Aug 01.
Article in English | MEDLINE | ID: mdl-2390057

ABSTRACT

Polyamines are polycationic molecules essential for cell growth and differentiation. Recent work has focused on cell polyamine-transport systems as a way to regulate intracellular polyamine levels. In this study, we demonstrate the presence of two different active transporters for putrescine and spermidine in a rat tumoral cell line (AR4-2J). The first has a Km of 3.1 microM and a Vmax of 3.7 pmol/15 min per micrograms of DNA for putrescine and the second a Km of 0.42 microM and a Vmax of 4.7 pmol/15 min per micrograms of DNA for spermidine. Competition studies performed between the polyamines confirm the difference between these two carriers; one has an equal affinity for the three main polyamines, and the other has a lower affinity for putrescine. Amino acids do not share this transport system, which is Na(+)-independent. Choline chloride inhibits selectively and in a dose-responsive manner the uptake of putrescine without affecting that of spermidine. These data demonstrate that AR4-2J cells possess two polyamine transporters; one is specific for aminopropyl groups (spermidine and spermine), and the other is choline-sensitive, but cannot discriminate between aminobutyl (putrescine) and aminopropyl groups.


Subject(s)
Pancreatic Neoplasms/metabolism , Putrescine/pharmacokinetics , Spermidine/pharmacokinetics , Amino Acids/pharmacology , Animals , Biological Transport , Intracellular Fluid/metabolism , Kinetics , Rats , Sodium/pharmacology , Tumor Cells, Cultured
12.
Arch Mal Coeur Vaiss ; 83(7): 937-45, 1990 Jun.
Article in French | MEDLINE | ID: mdl-2114853

ABSTRACT

Doppler echocardiography was performed in 112 patients with normal aortic valve prostheses and 13 patients with dysfunction (3 obstructions, 10 regurgitations) confirmed at catheterisation and/or surgery. The maximum and mean transprosthetic pressure gradients were measured in all patients by continuous wave Doppler. The prosthetic valve surface area was calculated by applying the continuity equation in the last 67 patients and compared with the effective surface area deduced from hemodynamic studies in the literature: --There was a great variability in the values of mean pressure gradient and prosthetic valve area within each group and with each size of prosthesis in patients with normal valves. No significant difference was observed between the gradients of different prostheses. However, for a given size, the St Jude Medical prosthesis had larger calculated surface areas than the other prostheses. The Doppler valve surface area did not differ significantly from the area measured invasively for the different categories of prostheses, and it increased with the size of the prosthesis. Mild aortic regurgitation was observed in 16 per cent of bioprostheses and 30 per cent of mechanical prostheses. The three cases of obstruction were characterised by a high mean pressure gradient (59 +/- 16 mmHg, p less than 0.01 vs normal prostheses) and a reduced Doppler surface area (0.7 +/- 0.2 cm2, p less than 0.005 vs normal prostheses) and were correctly diagnosed by Doppler echocardiography. Eight of the ten prosthetic regurgitations were correctly quantified by Doppler. Cardiac Doppler coupled with echocardiography is a very valuable method of non-invasive assessment of aortic valve prostheses.(ABSTRACT TRUNCATED AT 250 WORDS)


Subject(s)
Echocardiography, Doppler , Heart Valve Prosthesis , Adolescent , Adult , Age Factors , Aged , Aged, 80 and over , Aortic Valve , Female , Follow-Up Studies , Hemodynamics , Humans , Male , Middle Aged , Prosthesis Failure
14.
Digestion ; 46 Suppl 2: 162-5, 1990.
Article in English | MEDLINE | ID: mdl-2262049

ABSTRACT

Basic fibroblast growth factor (bFGF) is a potent mitogen for various cell types. We report here the first study of the effects of bFGF on a digestive tract-derived cell line. The effect of bFGF on the proliferation of AR4-2J cells, tumor cells of acinar pancreatic origin, was investigated together with modulation of ornithine decarboxylase (ODC) activity, an intracellular event involved in cell proliferation. bFGF caused a concentration-dependent stimulation of AR4-2J cell growth, with a half maximal effect (EC50) at 22 +/- 2 pM. ODC activity, assayed by the CO2-trapping method, was also increased by bFGF in a dose-dependent manner, reaching half-maximal stimulation at 20 pM. We conclude that bFGF is a very potent growth promoting factor for cells of pancreatic origin, already effective at picomolar concentrations. The parallelism between the growth assay and the ODC activity assay implicates the involvement of ODC activity in the pathway of the mitogenic effect of bFGF. The stimulation of ODC activity therefore seems to be a reliable early marker for cell proliferation in this model.


Subject(s)
Fibroblast Growth Factors/physiology , Pancreatic Neoplasms/pathology , Animals , Cell Division , Cell Line , Ornithine Decarboxylase/metabolism , Rats , Tumor Cells, Cultured/cytology
15.
Digestion ; 46 Suppl 2: 166-9, 1990.
Article in English | MEDLINE | ID: mdl-2262050

ABSTRACT

Recent studies have demonstrated the presence of both CCKA and CCKB receptors on dog and guinea pig pancreas. Although CCKA receptors are implicated in enzymatic secretion, biological effects of CCKB receptors are still unknown. We have previously found that a rat acinar pancreatic cell line (AR4-2J) possesses both receptor subtypes. In this work we report the ability of various CCK/gastrin agonists and antagonists to bind with these receptors. We found that gastrin, pentagastrin and Gastrin/CCK4 induce ornithine decarboxylase activity, an early event involved in cell proliferation, as well as 3H-thymidine incorporation. Furthermore, these effects occur at doses at which these peptides interact only with the CCKB receptor subtype. In view of these data we propose that modulation of AR4-2J cell growth by gastrin agonists specifically involve occupation of the CCKB receptor.


Subject(s)
Gastrins/physiology , Pancreas/cytology , Receptors, Cholecystokinin/metabolism , Signal Transduction/physiology , Animals , Cell Division/physiology , Cell Line , Ornithine Decarboxylase/metabolism , Rats , Receptors, Cholecystokinin/drug effects
16.
J Mal Vasc ; 15(1): 55-62, 1990.
Article in French | MEDLINE | ID: mdl-2179448

ABSTRACT

Dipyridamole thallium scintigraphy (tomo SMTD) (fig. 2) and a bicycle stress-testing ECG were performed in a prospective study of 102 patients (Tabl. VIII) referred for aortic reconstruction surgery with aortic cross-clamping (fig. 1), carried out without knowledge of tomo SMTD results. A clinical coronary artery disease (CAD) was suspected in 45 patients (44%). The exercise test (tabl. IV) was inadequate in 78%, normal in 11% and abnormal in 11% of patients. Tomo SMTD (tabl. VI et X) was normal in 60 patients (59%), abnormal with persistent defect in 21 (20.5%) and abnormal with transient defect in 21 (20.5%). Post-operative cardiac events (tabl. I) occurred in 4 patients (3.9%): 2 deaths, 1 non-fatal myocardial infarction and 1 rest angina; but only 2 of these had documented CAD. All 4 had abnormal tomo SMTD (3 with transient, 1 with persistent defect). It is concludes that abnormal tomo SMTD had a significant pronostic value (p less than 0.03) in predicting post-perative cardiac events (tabl. XI, fig. 3) after abdominal aortic surgery with cross-clamping. This test facilitates selection of patients for coronary angiography.


Subject(s)
Aortic Diseases/surgery , Coronary Disease/diagnostic imaging , Postoperative Complications/diagnostic imaging , Aged , Aorta, Abdominal , Coronary Angiography , Dipyridamole , Female , Humans , Male , Middle Aged , Preoperative Care , Prospective Studies , Radionuclide Imaging , Risk Factors
17.
Am J Physiol ; 256(5 Pt 1): G846-50, 1989 May.
Article in English | MEDLINE | ID: mdl-2719109

ABSTRACT

Recent studies have demonstrated that cholecystokinin (CCK) receptors are heterologous in peripheral tissues and in the central nervous system and that CCK-gastrin (CCK-G) peptides are potent trophic factors for the gastrointestinal tract. In the present study we used 125I-labeled gastrin and 125I-labeled CCK to demonstrate the heterogeneity of CCK receptors on a rat pancreatic acinar cell line (AR4-2J) and analyze the role of these receptors in increasing the activity of ornithine decarboxylase. Pharmacological analysis of radioligand binding fit well with the presence of two different receptors: 1) a CCK-selective receptor having the characteristics of the CCK receptor present on normal pancreatic cells and 2) a high-affinity, low-selectivity CCK-G binding site that interacts with all CCK-G peptides sulfated and nonsulfated. CCK-G peptides stimulate ornithine decarboxylase activity with the following order of potencies (EC50): G-(2-17)-ds (0.1 nM) greater than or equal to CCK-9 (0.25 nM) greater than or equal to pentagastrin (0.4 nM) greater than CCK-4 (6 nM). This stimulation was not inhibited by CCK antagonist (asperlicin) at a concentration range that blocks the CCK receptor but does not compete with 125I-labeled gastrin binding to the CCK-G receptor. These results, obtained with CCK-G agonists and antagonists, demonstrate that ornithine decarboxylase stimulation in these cells is mediated via the CCK-G receptor.


Subject(s)
Cholecystokinin/pharmacology , Gastrins/pharmacology , Ornithine Decarboxylase/analysis , Pancreas/enzymology , Animals , Benzodiazepinones/pharmacology , Cell Line , Cholecystokinin/metabolism , Dose-Response Relationship, Drug , Pancreas/drug effects , Rats , Receptors, Cholecystokinin/analysis , Receptors, Cholecystokinin/drug effects
18.
Endocrinology ; 124(2): 1017-25, 1989 Feb.
Article in English | MEDLINE | ID: mdl-2563240

ABSTRACT

Somatostatin has been demonstrated to negatively regulate pancreatic growth in vivo. In this study we used the AR4-2J rat pancreatic acinar tumor cell line to investigate the effect of a stable somatostatin analog, SMS 201-995 (SMS) on cell proliferation. SMS induced an antiproliferative effect on both serum or epidermal growth factor (EGF)-induced cell proliferation; exposure of the cells for 48 h to SMS caused a slight inhibition of serum-induced proliferation (maximal inhibition, 26%) and abolished the growth-promoting effect of EGF. Maximal effect was observed with 10 nM SMS, and half-maximal (IC50) effect with 0.06-0.1 nM SMS. Binding studies with an iodinated derivative of SMS, [125I-Tyr3]SMS, revealed the presence of a single class of high affinity binding sites on AR4-2J plasma membranes with an equilibrium dissociation constant of 0.2 +/- 0.03 nM and a binding site number of 1.1 +/- 0.07 pmol/mg protein. Addition of the nonhydrolyzable GTP analog, guanosine 5-[gamma-thio] triphosphate (GTP gamma S), increased the rate of dissociation of the specifically bound peptide in agreement with the coupling of somatostatin receptors with a GTP-binding regulatory protein. The good agreement between the IC50 for SMS inhibition of cell proliferation and the apparent Kd for binding indicates that the characterized binding sites are the somatostatin receptors that mediate the antiproliferative effect of SMS. When cells were grown in serum-free medium EGF stimulated AR4-2J cell proliferation with half-maximal (ED50) and maximal effects at 0.6 and 10 nM EGF, respectively. This stimulatory effect of EGF was mediated by specific receptors, since binding studies with [125I]EGF indicated that AR4-2J cells contained a single class of EGF receptors (13,000 sites/cell), with an affinity constant for [125I]EGF (Kd = 0.9 +/- 0.09 nM) close to the ED50 for EGF stimulation of cell growth. To examine if SMS-induced growth inhibition involved a cAMP-dependent mechanism we first studied the effect of SMS on cAMP production. SMS had no effect on basal cAMP, but completely inhibited VIP-stimulated cAMP production with an IC50 of 0.2 nM. Pertussis toxin, which is known to abolish the inhibitory effect of somatostatin on adenylate cyclase activity in AR4-2J cells, did not reverse the ability of SMS to inhibit cell proliferation as well as EGF-induced cell proliferation. These data indicate that the antiproliferative effect of SMS does not involve the GTP-binding protein-mediated negative coupling of somatostatin receptors to adenylate cyclase.(ABSTRACT TRUNCATED AT 400 WORDS)


Subject(s)
Adenylate Cyclase Toxin , Cell Division/drug effects , GTP-Binding Proteins/physiology , Octreotide/pharmacology , Pertussis Toxin , Somatostatin/antagonists & inhibitors , Virulence Factors, Bordetella/pharmacology , Animals , Cell Line , Cyclic AMP/biosynthesis , DNA Replication/drug effects , Epidermal Growth Factor/pharmacology , ErbB Receptors/metabolism , Kinetics , Pancreatic Neoplasms , Receptors, Neurotransmitter/metabolism , Receptors, Somatostatin , Somatostatin/metabolism , Somatostatin/pharmacology , Thymidine/metabolism
19.
Acta Med Hung ; 46(4): 235-43, 1989.
Article in English | MEDLINE | ID: mdl-2483997

ABSTRACT

This paper was addressed to know whether early events in mitogenesis (activation of the Na+/H+, activation of ornithine decarboxylase and formation of cyclic AMP) are involved in pancreatic cell proliferation and mediate secretory process. The AR4-2J cell line was used. Analogues of amiloride inhibited cell proliferation but had no effect on amylase release. Activation of ornithine decarboxylase was triggered via a CCK B receptor type not involved in pancreatic secretion. Inhibition of cyclic AMP was not involved in inhibition of cell proliferation caused by somatostatin. Specific effectors might be related either to the secretory or to the trophic pathway. Another possibility is that multiple receptor sub-classes are linked to specific pathways.


Subject(s)
Pancreas/metabolism , Amiloride/analogs & derivatives , Amiloride/pharmacology , Amino Acid Sequence , Amylases/metabolism , Animals , Cell Division/drug effects , Cell Line , Cholecystokinin/analogs & derivatives , Cholecystokinin/pharmacology , DNA Replication/drug effects , Molecular Sequence Data , Ornithine Decarboxylase/metabolism , Pancreas/drug effects , Pancreas/physiology , Sodium/metabolism , Somatostatin/pharmacology , Virulence Factors, Bordetella/pharmacology
20.
FEBS Lett ; 242(1): 61-4, 1988 Dec 19.
Article in English | MEDLINE | ID: mdl-3203744

ABSTRACT

(Thr28,Nle31)CCK(23-33) (CCK-9) and gastrin(1-17)I (gastrin) inhibited adenylate cyclase activity in membranes from the tumoral rat pancreatic acinar cell line AR 4-2J through a Bordetella pertussis toxin-sensitive mechanism. This contrasted with the stimulatory effect exerted by CCK-9 on adenylate cyclase activity in membranes from normal rat pancreas. The relative potency of CCK-9, gastrin, and related peptides in inhibiting adenylate cyclase, when confronted with previous evidence, suggests that 'non-selective CCK-gastrin CCK-B receptors' predominating over 'selective CCK-A receptors' in the AR 4-2J cell line, favored the coupling of the first receptors to adenylate cyclase through Gi, while CCK-A receptors capable of stimulating the enzyme through Gs were detected only after Bordetella pertussis toxin pretreatment.


Subject(s)
Adenylate Cyclase Toxin , Adenylyl Cyclase Inhibitors , Cholecystokinin/pharmacology , Gastrins/pharmacology , Pancreas/enzymology , Pancreatic Neoplasms/enzymology , Pertussis Toxin , Virulence Factors, Bordetella/pharmacology , Animals , Cell Membrane/enzymology , Guanosine Triphosphate/pharmacology , Pentagastrin/pharmacology , Peptide Fragments/pharmacology , Rats , Secretin/pharmacology , Tetragastrin/pharmacology , Tumor Cells, Cultured , Vasoactive Intestinal Peptide/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...